Houston, Texas 77030


This study will further the understanding of the genetic events leading to the development of RCC; explore the genetic basis for genetic instability and how it affects cancer risk; and eventually provide a means of identifying a subgroup of individuals who are most likely to develop RCC. Such individuals may then be targeted for intervention programs such as chemoprevention or dietary modification.


Inclusion Criteria: - Adult patients of any ethnicity or sex, who have a been diagnosed with possible Renal Cell Carcinoma within the past year. Exclusion Criteria: - Must not have received chemotherapy, biological therapy or radiation therapy in the 6 months preceding enrollment will - Must not have had RCC, or metastatic RCC, - Must not have had a renal transplantation



Primary Contact:

Principal Investigator
Seth P. Lerner, MD
Baylor College of Medicine

Carmen Bedford
Phone: 713-798-2179
Email: bedford@bcm.edu

Backup Contact:


Location Contact:

Houston, Texas 77030
United States

Phone: 713-745-2485
Email: xwu@mdanderson.org

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.